325 related articles for article (PubMed ID: 19025063)
21. Synthesis and antitumor activity of novel 6-aryl and 6-alkylpyrazolo[3,4-d]pyrimidin-4-one derivatives.
el-Enany MM; Kamel MM; Khalil OM; el-Nassan HB
Eur J Med Chem; 2010 Nov; 45(11):5286-91. PubMed ID: 20846758
[TBL] [Abstract][Full Text] [Related]
22. Efficient synthesis and biological evaluation of some 2,4-diamino-furo[2,3-d]pyrimidine derivatives.
Hu YG; Wang Y; Du SM; Chen XB; Ding MW
Bioorg Med Chem Lett; 2010 Nov; 20(21):6188-90. PubMed ID: 20850310
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and biological evaluation of certain new thiazolopyrimidines.
el-Bendary ER; el-Sherbeny MA; Badria FA
Boll Chim Farm; 1998 Apr; 137(4):115-9. PubMed ID: 9618969
[TBL] [Abstract][Full Text] [Related]
24. Novel 5-(2-hydroxyphenyl)-3-substituted-2,3-dihydro-1,3,4-oxadiazole-2-thione derivatives: promising anticancer agents.
Aboraia AS; Abdel-Rahman HM; Mahfouz NM; El-Gendy MA
Bioorg Med Chem; 2006 Feb; 14(4):1236-46. PubMed ID: 16242340
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and antiproliferative activity in vitro of new 2-, 3- or 4-substituted pyrido[2',3':3,4]pyrazolo[1, 5-a]pyrimidines.
Poreba K; Wietrzyk J; Opolski A
Acta Pol Pharm; 2006; 63(3):189-94. PubMed ID: 20085223
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and biological investigations of some novel thiazolylbenzimidazoles, and benzimidazolyl-thiazolo[4,5-d]pyrimidines.
Habib NS; Rida SM; Badawey EA; Fahmy HT; Ghozlan HA
Pharmazie; 1997 May; 52(5):346-50. PubMed ID: 9183785
[TBL] [Abstract][Full Text] [Related]
27. Pyrimidines. Part II: Synthesis of novel pyrimidines, 1,2,4-triazolo[4,3-a]pyrimidin-7-ones and pyrimidino[2,1-c][1,2,4]triazin-8-ones for their antimicrobial and anticancer activities.
Habib NS; Soliman R; Ismail K; Hassan AM; Sarg MT
Boll Chim Farm; 2003 Nov; 142(9):396-405. PubMed ID: 14971308
[TBL] [Abstract][Full Text] [Related]
28. Design and synthesis of some novel hydrazide, 1,2-dihydropyridine, chromene derivatives carrying biologically active sulfone moieties with potential anticancer activity.
Bashandy MS; Al-Said MS; Al-Qasoumi SI; Ghorab MM
Arzneimittelforschung; 2011; 61(9):521-6. PubMed ID: 22029229
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and biological evaluation of thiazolidine-2,4-dione and 2,4-thione derivatives as inhibitors of translation initiation.
Chen H; Fan YH; Natarajan A; Guo Y; Iyasere J; Harbinski F; Luus L; Christ W; Aktas H; Halperin JA
Bioorg Med Chem Lett; 2004 Nov; 14(21):5401-5. PubMed ID: 15454234
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and antitumor activities of some 4,5-dihydro-1H-1,2,4-triazol-5-ones.
Ikizler AA; Ikizler A; Serdar M; Yildirim N
Acta Pol Pharm; 1997; 54(5):363-70. PubMed ID: 9584694
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and primary cytotoxicity evaluation of new imidazo[2,1-b]thiazole derivatives.
Gürsoy E; Güzeldemirci NU
Eur J Med Chem; 2007 Mar; 42(3):320-6. PubMed ID: 17145120
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of N-{4-[(2,4-diamino-5-methyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)thio]benzoyl}-L-glutamic acid and N-{4-[(2-amino-4-oxo-5-methyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)thio]benzoyl}-L-glutamic acid as dual inhibitors of dihydrofolate reductase and thymidylate synthase and as potential antitumor agents.
Gangjee A; Lin X; Kisliuk RL; McGuire JJ
J Med Chem; 2005 Nov; 48(23):7215-22. PubMed ID: 16279780
[TBL] [Abstract][Full Text] [Related]
33. Synthesis of some new derivatives of thiazolo-[3,2-a]pyrimidine-3,5,7(2H)-trione of potential biological activity.
al-Thebeiti MS
Boll Chim Farm; 2001; 140(4):221-3. PubMed ID: 11570216
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and antitumor activity of substituted triazolo[4,3-a]pyrimidin-6-sulfonamide with an incorporated thiazolidinone moiety.
Hafez HN; El-Gazzar AR
Bioorg Med Chem Lett; 2009 Aug; 19(15):4143-7. PubMed ID: 19540114
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and anticancer activity evaluation of 4-thiazolidinones containing benzothiazole moiety.
Havrylyuk D; Mosula L; Zimenkovsky B; Vasylenko O; Gzella A; Lesyk R
Eur J Med Chem; 2010 Nov; 45(11):5012-21. PubMed ID: 20810193
[TBL] [Abstract][Full Text] [Related]
36. A study on some 4,5-dihydro-1H-1,2,4-triazol-5-one derivatives.
Kahveci B; Ikizler AA
Acta Pol Pharm; 2000; 57(2):119-22. PubMed ID: 10934790
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and differential antiproliferative activity of Biginelli compounds against cancer cell lines: Monastrol, oxo-monastrol and oxygenated analogues.
Russowsky D; Canto RF; Sanches SA; D'Oca MG; de Fátima A; Pilli RA; Kohn LK; Antônio MA; de Carvalho JE
Bioorg Chem; 2006 Aug; 34(4):173-82. PubMed ID: 16765411
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of pyrrolo[2,3-d]pyrimidine derivatives and their antiproliferative activity against melanoma cell line.
Jung MH; Kim H; Choi WK; El-Gamal MI; Park JH; Yoo KH; Sim TB; Lee SH; Baek D; Hah JM; Cho JH; Oh CH
Bioorg Med Chem Lett; 2009 Dec; 19(23):6538-43. PubMed ID: 19857963
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and in vitro-anticancer and antimicrobial evaluation of some novel quinoxalines derived from 3-phenylquinoxaline-2(1H)-thione.
El-Hawash SA; Wahab AE
Arch Pharm (Weinheim); 2006 Aug; 339(8):437-47. PubMed ID: 16881038
[TBL] [Abstract][Full Text] [Related]
40. Preparation, characterization & anticancer evaluation of potassium N-(p-anisole)-alpha-(2-xanthatophenyl)nitrone.
Khallow KI; Ezzat SS; al-Omari NA
Boll Chim Farm; 2002; 141(6):447-52. PubMed ID: 12577515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
